The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III trial (ZJBIO009): CMAB009 plus irinotecan versus irinotecan alone as second-line treatment after fluoropyrimidine and oxaliplatin failure in wild-type K-ras metastatic colorectal cancer patients.
 
Yuankai Shi
No Relationships to Disclose
 
Jin Li
No Relationships to Disclose
 
Jianming Xu
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Wei Liu
No Relationships to Disclose
 
Yigui Cheng
No Relationships to Disclose
 
Li Bai
No Relationships to Disclose
 
Yiping Zhang
No Relationships to Disclose
 
Xiaohui He
No Relationships to Disclose
 
Yi Luo
No Relationships to Disclose
 
Yunpeng Liu
No Relationships to Disclose
 
Qiang Yao
No Relationships to Disclose
 
Yuhong Li
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Xiaohua HU
No Relationships to Disclose
 
Yajun Guo
No Relationships to Disclose
 
Yan Sun
No Relationships to Disclose